SAFETY OF BMS 186716 IN THE TREATMENT OF HEART FAILURE
SAFETY OF BMS 186716 IN THE TREATMENT OF HEART FAILURE
批准号:
6425972
负责人:
MARK A MUNGER
金额:
$0.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30
中文摘要
这项多机构的D类研究已经完成。该研究药物是中性内肽酶和血管紧张素转换酶的选择性竞争性抑制剂。抑制中性内肽酶可防止心房自然肽和脑自然肽的酶失活,增强利尿和血管舒张作用。由于血管紧张素转换酶抑制增加循环肾素,中性内肽酶可能通过引起心房自然肽的增加而拮抗这种作用,从而抑制肾素的分泌。本研究收集的数据被转发给工业赞助商。研究结果将在所有参与中心的数据分析完成后公布。
英文摘要
This multi-institutional, category D study has been completed. The study drug is a selective competitive inhibitor of neutral endopeptidase and angiotensin-converting enzyme. Inhibition of neutral endopeptidase prevents enzymatic inactivation of atrial naturetic peptide and brain naturetic peptide, potentiating diuretic and vasodilatory effects. Since angiotensin-converting enzyme inhibition increases circulating renin, neutral endopeptidase may antagonize this effect by causing an increase in atrial naturetic peptide, which inhibits renin secretion. Data collected on this study was forwarded to the industrial sponsor. Results of the study will be made available after data from all participating centers has been analyzed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CARVEDILOL TREATMENT FOR CHRONIC HEART FAILURE
-
批准号:7718500
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2008
-
负责人:MARK A MUNGER
-
依托单位:
CARVEDILOL TREATMENT FOR CHRONIC HEART FAILURE
-
批准号:7604958
-
项目类别:
-
资助金额:$6.68万
-
财政年份:2007
-
负责人:MARK A MUNGER
-
依托单位:
LEFT VENTRICULAR SYSTOLIC AND/OR DIASTOLIC DYSFUNCTION
-
批准号:7201420
-
项目类别:
-
资助金额:$2.27万
-
财政年份:2005
-
负责人:MARK A MUNGER
-
依托单位:
Left ventricular systolic and/or diastolic dysfunction
-
批准号:7044775
-
项目类别:
-
资助金额:$1.57万
-
财政年份:2004
-
负责人:MARK A MUNGER
-
依托单位:
SAFETY OF BMS 186716 IN THE TREATMENT OF HEART FAILURE
-
批准号:6218433
-
项目类别:
-
资助金额:$0.16万
-
财政年份:1998
-
负责人:MARK A MUNGER
-
依托单位:
MISOPROSTOL EFFECTS ON BLOOD PRESSURE CHANGES IN ESSENTIAL HYPERTENSION
-
批准号:6114855
-
项目类别:
-
资助金额:$2.81万
-
财政年份:1998
-
负责人:MARK A MUNGER
-
依托单位:
MISOPROSTOL EFFECTS ON BLOOD PRESSURE CHANGES IN ESSENTIAL HYPERTENSION
-
批准号:6425979
-
项目类别:
-
资助金额:$0.16万
-
财政年份:1998
-
负责人:MARK A MUNGER
-
依托单位:
SAFETY OF BMS 186716 IN THE TREATMENT OF HEART FAILURE
-
批准号:6114840
-
项目类别:
-
资助金额:$2.81万
-
财政年份:1998
-
负责人:MARK A MUNGER
-
依托单位:
MISOPROSTOL EFFECTS ON BLOOD PRESSURE CHANGES IN ESSENTIAL HYPERTENSION
-
批准号:6218448
-
项目类别:
-
资助金额:$0.16万
-
财政年份:1998
-
负责人:MARK A MUNGER
-
依托单位:
MISOPROSTOL EFFECTS ON BLOOD PRESSURE CHANGES IN ESSENTIAL HYPERTENSION
-
批准号:6276090
-
项目类别:
-
资助金额:$2.66万
-
财政年份:1997
-
负责人:MARK A MUNGER
-
依托单位:
SAFETY OF BMS 186716 IN THE TREATMENT OF HEART FAILURE
-
批准号:6276075
-
项目类别:
-
资助金额:$2.66万
-
财政年份:1997
-
负责人:MARK A MUNGER
-
依托单位:
SAFETY OF BMS 186716 IN THE TREATMENT OF HEART FAILURE
-
批准号:6245961
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1997
-
负责人:MARK A MUNGER
-
依托单位:
MULTICENTER, RANDOMIZED STUDY OF IRBESARTAN IN HEART FAILURE TREATMENT
-
批准号:6245942
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1997
-
负责人:MARK A MUNGER
-
依托单位:
PILOT STUDY OF THE EFFECTS OF PENTOXIFYLLINE IN CHRONIC SEVERE HEART FAILURE
-
批准号:6245911
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1997
-
负责人:MARK A MUNGER
-
依托单位:
SAFETY OF BMS 186716 IN THE TREATMENT OF HEART FAILURE
-
批准号:6304921
-
项目类别:
-
资助金额:$0.16万
-
财政年份:--
-
负责人:MARK A MUNGER
-
依托单位:
MULTICENTER, RANDOMIZED STUDY OF IRBESARTAN IN HEART FAILURE TREATMENT
-
批准号:5218684
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARK A MUNGER
-
依托单位:--
PILOT STUDY OF THE EFFECTS OF PENTOXIFYLLINE IN CHRONIC SEVERE HEART FAILURE
-
批准号:3740723
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARK A MUNGER
-
依托单位:
HEMODYNAMICS, CATECHOLAMINE & HEART RATE VARIABILITY EFFECTS OF IV D-SOTALOL
-
批准号:3740745
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARK A MUNGER
-
依托单位:
PILOT STUDY OF THE EFFECTS OF PENTOXIFYLLINE IN CHRONIC SEVERE HEART FAILURE
-
批准号:5218643
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARK A MUNGER
-
依托单位:--
MISOPROSTOL EFFECTS ON BLOOD PRESSURE CHANGES IN ESSENTIAL HYPERTENSION
-
批准号:6304928
-
项目类别:
-
资助金额:$0.16万
-
财政年份:--
-
负责人:MARK A MUNGER
-
依托单位:
海外基金